JAMA Neurology (@jamaneuro) 's Twitter Profile
JAMA Neurology

@jamaneuro

JAMA Neurology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

ID: 54956563

linkhttp://jamaneuro.com calendar_today08-07-2009 17:04:35

14,14K Tweet

61,61K Followers

250 Following

JAMA Neurology (@jamaneuro) 's Twitter Profile Photo
JAMA Neurology
@jamaneuro

a month ago

Lecanemab, an anti-β-amyloid immunotherapy used in Alzheimer Disease, bound to the amyloid plaques in all 15 Down syndrome cases studied (age 43 and over). Findings underscore the necessity for clinical trials to evaluate both safety & efficacy. ja.ma/3XkEGcF

Lecanemab, an anti-β-amyloid immunotherapy used in Alzheimer Disease, bound to the amyloid plaques in all 15 Down syndrome cases studied (age 43 and over). Findings underscore the necessity for clinical trials to evaluate both safety & efficacy. ja.ma/3XkEGcF